Coronary angiography shows us the silhouette of a vessel. Intravascular imaging shows us inside it. That distinction — between shadow and structure — is why IVUS and OCT have become indispensable tools in complex percutaneous coronary intervention.
When I perform a complex PCI — a calcified lesion, a bifurcation, a chronic total occlusion, or an unprotected left main — the angiogram tells me where the blockage is. But it cannot tell me the composition of the plaque, the true lumen dimensions, the degree of calcification, or whether my stent is well-apposed to the vessel wall. For those answers, I need a catheter-based imaging system that travels inside the artery.
This is not a new idea. Both IVUS (intravascular ultrasound) and OCT (optical coherence tomography) have been available for decades. What has changed is the evidence — and the clinical consensus that routine use of these tools in complex cases leads to measurably better outcomes.
How IVUS and OCT Differ — and When to Use Each
IVUS uses high-frequency sound waves to produce cross-sectional images of the coronary artery. It penetrates deeply into tissue, making it particularly useful for assessing large vessels, severe calcification, and plaque burden. The images are lower resolution than OCT but give excellent information about vessel dimensions and overall plaque architecture.
OCT, by contrast, uses near-infrared light. Its resolution is ten times higher than IVUS, making it superior for visualising stent strut apposition, detecting thin-cap fibroatheromas, assessing edge dissections, and characterising superficial plaque morphology. The trade-off is shallower tissue penetration — so in heavily calcified or fibrotic vessels, OCT may not give you the full picture.
"Angiography shows you the shape of the problem. Imaging shows you its nature. The two are not interchangeable — and treating them as though they are has real consequences for patients."
— Dr. Zaidoun Hajali, MD FSCAI FRCPIn practice, my choice between IVUS and OCT depends on the lesion type, the vessel size, and what clinical question I need to answer. For a calcified proximal LAD with uncertain plaque burden, I reach for IVUS. For a suspected stent underexpansion or a post-stenting edge dissection, OCT gives me the resolution I need. Many cases benefit from both, used at different stages of the procedure.
What Imaging Actually Changes in the Cath Lab
The most direct impact of intravascular imaging is stent sizing. Angiography systematically underestimates vessel diameter — often by 20 to 30 percent — because it shows only the contrast-filled lumen, not the true vessel wall. When I use IVUS or OCT, I routinely size my stent to the vessel reference diameter, not the angiographic estimate. The result is better expansion, better apposition, and a significant reduction in the risk of in-stent restenosis and stent thrombosis.
Imaging also transforms how I approach calcification. A heavily calcified lesion that looks manageable on angiography may, under OCT, reveal a 360-degree calcium ring that will prevent adequate stent expansion without dedicated lesion preparation. That finding changes my strategy entirely — from straightforward stenting to a planned sequence of rotational atherectomy or intravascular lithotripsy followed by stenting. Without imaging, I might deploy a stent into a vessel that cannot accommodate it properly, and only discover the problem when the patient returns with restenosis.
- IVUS is preferred for large vessels, severe calcification, and left main assessment due to its deeper tissue penetration.
- OCT provides superior resolution for stent apposition, edge dissections, and thin-cap plaque characterisation.
- Imaging-guided stent sizing consistently achieves larger minimum stent area — the most important predictor of long-term patency.
- Post-stenting imaging detects correctable complications in a significant proportion of cases that appeared satisfactory on angiography alone.
- Major trials including ULTIMATE, ILUMIEN III, and OPINION support imaging guidance as a Class IIa recommendation in current ESC guidelines.
The Evidence Base
The clinical evidence for intravascular imaging guidance is now robust enough that it has entered the mainstream of international guidelines. The ULTIMATE trial demonstrated a 38% relative reduction in major adverse cardiac events with IVUS-guided stenting compared with angiography alone. The ILUMIEN series of trials established similar benefits with OCT. Meta-analyses consistently show lower rates of target vessel failure, stent thrombosis, and repeat revascularisation in imaging-guided cohorts.
It is worth being clear about where the evidence is strongest: complex lesions — calcified vessels, bifurcations, long lesions, left main disease, and chronic total occlusions — show the clearest benefit. In simple, short, non-calcified lesions in a large vessel with an experienced operator, the incremental benefit is smaller. The art lies in matching the tool to the clinical scenario.
What This Means for Patients
If you have been told you need a stent and your cardiologist has discussed using intravascular imaging, this is a good sign. It means your procedure is being planned with precision rather than approximation. The IVUS or OCT catheter is inserted through the same access site, takes a few minutes to acquire images, and is then removed before or after stent deployment. You will not feel anything different during the imaging pass.
Not every centre performs imaging-guided PCI routinely. If you are facing a complex coronary intervention, it is entirely reasonable to ask your cardiologist whether intravascular imaging will be used — and why or why not.
